Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 135 entries
View as:

Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development

Phase: N/A Priority: Normal
NCT ID: NCT01445197 Org: User:
Start: 12/31/12 End: 12/31/13 Due: 12/31/14

A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT01390649 Org: User:
Start: 11/30/11 End: 09/30/14 Due: 09/30/15

C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)

Phase: N/A Priority: Normal
NCT ID: NCT00292981 Org: User:
Start: 08/31/05 End: 05/31/10 Due: 05/31/11

Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )

Phase: N/A Priority: Normal
NCT ID: NCT05568888 Org: User:
Start: 03/28/23 End: 10/29/24 Due: 10/29/25

Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01545050 Org: User:
Start: 06/30/12 End: 12/31/13 Due: 12/31/14

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT03221842 Org: User:
Start: 11/06/17 End: 01/20/21 Due: 01/20/22

Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease

Phase: N/A Priority: Normal
NCT ID: NCT00941616 Org: User:
Start: 06/30/09 End: 02/29/12 Due: 02/28/13

Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00261833 Org: User:
Start: 03/31/06 End: 09/30/12 Due: 09/30/13

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT05130970 Org: User:
Start: 02/03/22 End: 01/02/24 Due: 01/02/25

Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)

Phase: N/A Priority: Normal
NCT ID: NCT00719680 Org: User:
Start: 06/30/08 End: 06/30/10 Due: 06/30/11

Fibrinogen Concentrate (Human) - Efficacy and Safety Study

Phase: N/A Priority: Normal
NCT ID: NCT00916656 Org: User:
Start: 10/31/09 End: 03/31/14 Due: 03/31/15

CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks

Phase: N/A Priority: Normal
NCT ID: NCT04656418 Org: User:
Start: 01/27/21 End: 06/07/22 Due: 06/07/23

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01475669 Org: User:
Start: 01/31/12 End: 09/30/14 Due: 09/30/15

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CSL730 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04446000 Org: User:
Start: 09/23/20 End: 03/28/23 Due: 03/28/24

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT05485961 Org: User:
Start: 10/21/22 End: 08/30/29 Due: 08/30/30

Study of Voncento® in Subjects With Von Willebrand Disease

Phase: N/A Priority: Normal
NCT ID: NCT02552576 Org: User:
Start: 10/05/15 End: 02/15/18 Due: 02/15/19

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00542997 Org: User:
Start: 09/30/07 End: 08/31/09 Due: 08/31/10

Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT02396342 Org: User:
Start: 06/10/15 End: 04/15/21 Due: 04/15/22

Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)

Phase: N/A Priority: Normal
NCT ID: NCT00322556 Org: User:
Start: 11/30/05 End: 04/30/08 Due: 04/30/09

Effects of CSL324 in the Lung After Segmental Challenge

Phase: N/A Priority: Normal
NCT ID: NCT05653713 Org: User:
Start: 12/20/22 End: 07/21/23 Due: 07/21/24

Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT05360706 Org: User:
Start: 03/18/21 End: 05/31/26 Due: 05/31/27

Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT01233440 Org: User:
Start: 10/31/10 End: 07/31/11 Due: 07/31/12

Effect of Food on the Oral Bioavailability of a Prolonged-release Formulation of Vamifeport in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06996184 Org: User:
Start: 05/27/25 End: 07/02/25 Due: 07/02/26

Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.

Phase: N/A Priority: Normal
NCT ID: NCT00670007 Org: User:
Start: 04/30/08 End: 09/30/14 Due: 09/30/15

Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy

Phase: N/A Priority: Normal
NCT ID: NCT01184846 Org: User:
Start: 11/30/10 End: 11/30/11 Due: 11/30/12